TCL Archive JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials November 19, 2010
TCL Archive In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says February 12, 1999
TCL Archive Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation September 27, 1985
TCL Archive ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections January 6, 2012